Literature DB >> 26056300

Structural basis for mutation-induced destabilization of profilin 1 in ALS.

Sivakumar Boopathy1, Tania V Silvas2, Maeve Tischbein1, Silvia Jansen3, Shivender M Shandilya2, Jill A Zitzewitz2, John E Landers1, Bruce L Goode3, Celia A Schiffer2, Daryl A Bosco4.   

Abstract

Mutations in profilin 1 (PFN1) are associated with amyotrophic lateral sclerosis (ALS); however, the pathological mechanism of PFN1 in this fatal disease is unknown. We demonstrate that ALS-linked mutations severely destabilize the native conformation of PFN1 in vitro and cause accelerated turnover of the PFN1 protein in cells. This mutation-induced destabilization can account for the high propensity of ALS-linked variants to aggregate and also provides rationale for their reported loss-of-function phenotypes in cell-based assays. The source of this destabilization is illuminated by the X-ray crystal structures of several PFN1 proteins, revealing an expanded cavity near the protein core of the destabilized M114T variant. In contrast, the E117G mutation only modestly perturbs the structure and stability of PFN1, an observation that reconciles the occurrence of this mutation in the control population. These findings suggest that a destabilized form of PFN1 underlies PFN1-mediated ALS pathogenesis.

Entities:  

Keywords:  X-ray crystallography; amyotrophic lateral sclerosis; profilin 1; protein misfolding; protein stability

Mesh:

Substances:

Year:  2015        PMID: 26056300      PMCID: PMC4491777          DOI: 10.1073/pnas.1424108112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Profilin binds proline-rich ligands in two distinct amide backbone orientations.

Authors:  N M Mahoney; D A Rozwarski; E Fedorov; A A Fedorov; S C Almo
Journal:  Nat Struct Biol       Date:  1999-07

2.  The role of profilin in actin polymerization and nucleotide exchange.

Authors:  E Korenbaum; P Nordberg; C Björkegren-Sjögren; C E Schutt; U Lindberg; R Karlsson
Journal:  Biochemistry       Date:  1998-06-30       Impact factor: 3.162

3.  Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding.

Authors:  J K Myers; C N Pace; J M Scholtz
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

4.  Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.

Authors:  Lisette G G C Verhoef; Kristina Lindsten; Maria G Masucci; Nico P Dantuma
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

5.  Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.

Authors:  Moses Prabu-Jeyabalan; Ellen A Nalivaika; Keith Romano; Celia A Schiffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Mutagenesis of human profilin locates its poly(L-proline)-binding site to a hydrophobic patch of aromatic amino acids.

Authors:  C Björkegren; M Rozycki; C E Schutt; U Lindberg; R Karlsson
Journal:  FEBS Lett       Date:  1993-10-25       Impact factor: 4.124

7.  What are pharmacological chaperones and why are they interesting?

Authors:  Dagmar Ringe; Gregory A Petsko
Journal:  J Biol       Date:  2009-10-13

8.  Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life.

Authors:  James A Austin; Gareth S A Wright; Seiji Watanabe; J Günter Grossmann; Svetlana V Antonyuk; Koji Yamanaka; S Samar Hasnain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

9.  Profilin1 E117G is a moderate risk factor for amyotrophic lateral sclerosis.

Authors:  Pietro Fratta; James Charnock; Toby Collins; Anny Devoy; Robin Howard; Andrea Malaspina; Richard Orrell; Katie Sidle; Jan Clarke; Maryam Shoai; Ching-Hua Lu; John Hardy; Vincent Plagnol; Elizabeth M C Fisher
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-12-05       Impact factor: 10.154

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  28 in total

1.  CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Samir Abdelkarim; Sarah Morgan; Vincent Plagnol; Ching-Hua Lu; Gary Adamson; Robin Howard; Andrea Malaspina; Richard Orrell; Nikhil Sharma; Katie Sidle; Jan Clarke; Nick C Fox; Martin N Rossor; Jason D Warren; Camilla N Clark; Jonathan D Rohrer; Elizabeth M C Fisher; Simon Mead; Alan Pittman; Pietro Fratta
Journal:  Brain       Date:  2015-09-11       Impact factor: 13.501

2.  Arp2/3 and Mena/VASP Require Profilin 1 for Actin Network Assembly at the Leading Edge.

Authors:  Kristen Skruber; Peyton V Warp; Rachael Shklyarov; James D Thomas; Maurice S Swanson; Jessica L Henty-Ridilla; Tracy-Ann Read; Eric A Vitriol
Journal:  Curr Biol       Date:  2020-05-28       Impact factor: 10.834

3.  Profilin Directly Promotes Microtubule Growth through Residues Mutated in Amyotrophic Lateral Sclerosis.

Authors:  Jessica L Henty-Ridilla; M Angeles Juanes; Bruce L Goode
Journal:  Curr Biol       Date:  2017-11-09       Impact factor: 10.834

4.  Stability of an aggregation-prone partially folded state of human profilin-1 correlates with aggregation propensity.

Authors:  Edoardo Del Poggetto; Angelo Toto; Chiara Aloise; Francesco Di Piro; Ludovica Gori; Francesco Malatesta; Stefano Gianni; Fabrizio Chiti; Francesco Bemporad
Journal:  J Biol Chem       Date:  2018-05-14       Impact factor: 5.157

5.  Structural, Functional, and Immunological Characterization of Profilin Panallergens Amb a 8, Art v 4, and Bet v 2.

Authors:  Lesa R Offermann; Caleb R Schlachter; Makenzie L Perdue; Karolina A Majorek; John Z He; William T Booth; Jessica Garrett; Krzysztof Kowal; Maksymilian Chruszcz
Journal:  J Biol Chem       Date:  2016-05-26       Impact factor: 5.157

6.  A Drosophila model of ALS reveals a partial loss of function of causative human PFN1 mutants.

Authors:  Chi-Hong Wu; Anthony Giampetruzzi; Helene Tran; Claudia Fallini; Fen-Biao Gao; John E Landers
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

Review 7.  Profilin1 biology and its mutation, actin(g) in disease.

Authors:  Duah Alkam; Ezra Z Feldman; Awantika Singh; Mahmoud Kiaei
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

8.  Profilin choreographs actin and microtubules in cells and cancer.

Authors:  Morgan L Pimm; Jessica Hotaling; Jessica L Henty-Ridilla
Journal:  Int Rev Cell Mol Biol       Date:  2020-07-16       Impact factor: 6.813

9.  Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.

Authors:  Chunxing Yang; Eric W Danielson; Tao Qiao; Jake Metterville; Robert H Brown; John E Landers; Zuoshang Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

Review 10.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.